Skip to main content

Praxis Precision Medicines, Inc.

PRAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689548

No open-market purchases or sales by Praxis Precision Medicines, Inc. insiders were filed in the last 90 days; 309 institutions reported holding it in 13F filings for Q2 2026, worth $11.3B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Praxis Precision Medicines, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of PRAX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders78174−3
Shares117.1M75.0K114.4M−2.60M (−2.2%)
Value$134.6M$86.3K$195.6M+$61.1M (+45.4%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PRAX in Q3 2023
InstitutionSharesValue% of portfolio
Ikarian Capital, LLC2,250,000$3.85M1.43%
Marshall Wace, LLP626,669$1.07M0.00%
Boothbay Fund Management, LLC453,150$774.9K0.03%
Atom Investors LP102,779$175.8K0.04%
Jump Financial, LLC32,659$55.8K0.00%
PCG Wealth Advisors, LLC29,500$50.4K0.03%
Prudential Financial Inc16,700$28.6K0.00%
Farther Finance Advisors, LLC15,000$25.6K0.00%
Victory Capital Management Inc12,568$21.5K0.00%
GWM Advisors LLC3,122$5.34K0.00%
IFP Advisors, Inc500$8550.00%

Sold out (14)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of PRAX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Maven Securities LTD1,351,442$1.55M
Harvard Management Co Inc692,617$797.0K
Federated Hermes, Inc.365,690$420.5K
CVI Holdings, LLC89,174$102.5K
Y-Intercept (Hong Kong) Ltd67,177$77.3K
Old Mission Capital LLC25,040$28.8K
Engineers Gate Manager LP19,492$22.4K
XTX Topco Ltd18,130$20.9K
Ergoteles LLC15,167$17.4K
Tower Research Capital LLC (TRC)11,183$12.9K
Balyasny Asset Management LLC10,315$11.9K
UBS Group AG7,620$8.76K
Allworth Financial LP632$727
New York State Common Retirement Fund327$376

Not filed for Q3 2023 yet (1)

Institutions that held Praxis Precision Medicines, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRAX in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Tekla Capital Management LLC75,000$86.3K